IDXX - IDEXX Laboratories, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,775,4231,601,8921,485,807
Cost of Revenue799,987711,622669,691
Gross Profit975,436890,270816,116
Operating Expenses
Research Development101,12299,68198,263
Selling General and Administrative524,075482,465457,598
Non Recurring-8,2128,212
Total Operating Expenses---
Operating Income or Loss350,239299,912260,255
Income from Continuing Operations
Total Other Income/Expenses Net3,6562,4681,729
Earnings Before Interest and Taxes353,895302,380261,984
Interest Expense32,04929,23915,429
Income Before Tax321,846273,141246,555
Income Tax Expense99,79281,00664,604
Minority Interest13913073
Net Income From Continuing Ops222,045192,078181,906
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income222,045192,078181,906
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares222,045192,078181,906